Cancer Genomes: Continuing ProgressDOWNING, James R.The New England journal of medicine. 2009, Vol 361, Num 11, pp 1111-1112, issn 0028-4793, 2 p.Article

TGF-β signaling, tumor suppression, and acute lymphoblastic leukemiaDOWNING, James R.The New England journal of medicine. 2004, Vol 351, Num 6, pp 528-530, issn 0028-4793, 3 p.Article

Haploinsufficiency of AML1 results in a decrease in the number of LTR-HSCs while simultaneously inducing an increase in more mature progenitorsWEILI SUN; DOWNING, James R.Blood. 2004, Vol 104, Num 12, pp 3565-3572, issn 0006-4971, 8 p.Article

Genomics and the Continuum of Cancer CareMCDERMOTT, Ultan; DOWNING, James R; STRATTON, Michael R et al.The New England journal of medicine. 2011, Vol 364, Num 4, pp 340-350, issn 0028-4793, 11 p.Article

The role of the AML1 transcription factor in leukemogenesis : RUNX1/AML1 in hematopoiesis, angiogenesis, and leukemogenesisLORSBACH, Robert B; DOWNING, James R.International journal of hematology. 2001, Vol 74, Num 3, pp 258-265, issn 0925-5710Article

Global Genomic Characterization of Acute Lymphoblastic LeukemiaMULLIGHAN, Charles G; DOWNING, James R.Seminars in hematology. 2009, Vol 46, Num 1, pp 3-15, issn 0037-1963, 13 p.Article

Acute lymphoblastic leukemiaPUI, Ching-Hon; RELLING, Mary V; DOWNING, James R et al.The New England journal of medicine. 2004, Vol 350, Num 15, pp 1535-1548, issn 0028-4793, 14 p.Article

CREBBP mutations in relapsed acute lymphoblastic leukaemiaMULLIGHAN, Charles G; JINGHUI ZHANG; BUETOW, Kenneth H et al.Nature (London). 2011, Vol 471, Num 7337, pp 235-239, issn 0028-0836, 5 p.Article

New markers for minimal residual disease detection in acute lymphoblastic leukemiaCOUSTAN-SMITH, Elaine; GUANGCHUN SONG; DOWNING, James R et al.Blood. 2011, Vol 117, Num 23, pp 6267-6276, issn 0006-4971, 10 p.Article

Hierarchical Maintenance of MLL Myeloid Leukemia Stem Cells Employs a Transcriptional Program Shared with Embryonic Rather Than Adult Stem CellsSOMERVAILLE, Tim C. P; MATHENY, Christina J; SPENCER, Gary J et al.Cell stem cell. 2009, Vol 4, Num 2, pp 129-140, issn 1934-5909, 12 p.Article

PROMISE: a tool to identify genomic features with a specific biologically interesting pattern of associations with multiple endpoint variablesPOUNDS, Stan; CHENG CHENG; XUEYUAN CAO et al.Bioinformatics (Oxford. Print). 2009, Vol 25, Num 16, pp 2013-2019, issn 1367-4803, 7 p.Article

Treating Childhood Acute Lymphoblastic Leukemia without Cranial IrradiationPUI, Ching-Hon; CAMPANA, Dario; COUSTAN-SMITH, Elaine et al.The New England journal of medicine. 2009, Vol 360, Num 26, pp 2730-2741, issn 0028-4793, 12 p.Article

Favorable impact of the t(9;11) in childhood acute myeloid leukemiaRUBNITZ, Jeffrey E; RAIMONDI, Susana C; XIN TONG et al.Journal of clinical oncology. 2002, Vol 20, Num 9, pp 2302-2309, issn 0732-183XArticle

Treatment Outcomes in Black and White Children With Cancer: Results From the SEER Database and St Jude Children's Research Hospital, 1992 Through 2007PUI, Ching-Hon; DEQING PEI; JEHA, Sima et al.Journal of clinical oncology. 2012, Vol 30, Num 16, pp 2005-2012, issn 0732-183X, 8 p.Article

Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemiaHUINING KANG; CHEN, I.-Ming; AR, Kerem et al.Blood. 2010, Vol 115, Num 7, pp 1394-1405, issn 0006-4971, 12 p.Article

Risk of adverse events after completion of therapy for childhood acute lymphoblastic leukemiaPUI, Ching-Hon; DEQING PEI; CHENG CHENG et al.Journal of clinical oncology. 2005, Vol 23, Num 31, pp 7936-7941, issn 0732-183X, 6 p.Article

ALK-positive plasmablastic B-cell lymphoma with expression of the NPM-ALK fusion transcript: report of 2 casesONCIU, Mihaela; BEHM, Frederick G; DOWNING, James R et al.Blood. 2003, Vol 102, Num 7, pp 2642-2644, issn 0006-4971, 3 p.Article

Clinical significance of residual disease during treatment in childhood acute myeloid leukaemiaCOUSTAN-SMITH, Elaine; RIBEIRO, Raul C; DOWNING, James R et al.British journal of haematology. 2003, Vol 123, Num 2, pp 243-252, issn 0007-1048, 10 p.Article

Acute lymphoblastic leukemia in a developing country : Preliminary results of a nonrandomized clinical trial in El SalvadorBONILLA, Miguel; MORENO, Nelson; CRIST, William M et al.Journal of pediatric hematology/oncology. 2000, Vol 22, Num 6, pp 495-501, issn 1077-4114Conference Paper

A novel retinoblastoma therapy from genomic and epigenetic analysesJINGHUI ZHANG; BENAVENTE, Claudia A; BRENNAN, Rachel et al.Nature (London). 2012, Vol 481, Num 7381, pp 329-334, issn 0028-0836, 6 p.Article

Association of Age at Diagnosis and Genetic Mutations in Patients With NeuroblastomaCHEUNG, Nai-Kong V; JINGHUI ZHANG; CHEUNG, Irene Y et al.JAMA, the journal of the American Medical Association. 2012, Vol 307, Num 10, pp 1062-1071, issn 0098-7484, 10 p.Article

Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcomeHARVEY, Richard C; MULLIGHAN, Charles G; WILSON, Carla S et al.Blood. 2010, Vol 116, Num 23, pp 4874-4884, issn 0006-4971, 11 p.Article

Acquired variation outweighs inherited variation in whole genome analysis of methotrexate polyglutamate accumulation in leukemiaFRENCH, Deborah; WENJIAN YANG; CHENG CHENG et al.Blood. 2009, Vol 113, Num 19, pp 4512-4520, issn 0006-4971, 9 p.Article

BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of IkarosMULLIGHAN, Charles G; MILLER, Christopher B; RELLING, Mary V et al.Nature (London). 2008, Vol 452, Num 7191, pp 110-114, issn 0028-0836, 5 p.Article

Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemiaMULLIGHAN, Charles G; GOORHA, Salil; XIAOPING SU et al.Nature (London). 2007, Vol 446, Num 7137, pp 758-764, issn 0028-0836, 7 p.Article